Hawaii health authorities are suspending revocation of Pono Life Sciences’ medical cannabis pharmacy license


The U.S. state health department announced today that it has suspended an order revoking Pono Life Sciences’ medical cannabis dispensary license.

The health department issued the breach and order notice on May 11 after the company allegedly failed to file several annual independent financial audits as required by state law. The announcement revoked Pono Life Sciences’ license and asked the company to close its medical marijuana and retail operations in Maui.

During the suspension of the revocation, the licensee has up to 60 days to submit an audit for 2017, 90 days to submit an audit for 2018, and 120 days to submit the audit for 2019. It may resume medicinal cannabis production and retailing during the suspension of the withdrawal pending the submission of financial audits.

Correction: The State Department of Health today revoked the suspension of the medical cannabis pharmacy license for Pono Life Sciences on May 11th. An earlier version of this story and its headline stated that the department had suspended the license.

For our full coverage of the coronavirus outbreak, click here. Submit your coronavirus news tip.